Id |
Subject |
Object |
Predicate |
Lexical cue |
tok264 |
0-5 |
RB |
denotes |
Early |
tok265 |
6-15 |
JJ |
denotes |
antiviral |
tok266 |
16-25 |
NN |
denotes |
treatment |
tok267 |
26-31 |
MD |
denotes |
could |
tok268 |
32-41 |
VB |
denotes |
alleviate |
event34 |
32-41 |
OCCURRENCE |
denotes |
alleviate |
tok269 |
42-49 |
NN |
denotes |
disease |
tok270 |
50-58 |
NN |
denotes |
severity |
tok271 |
59-62 |
CC |
denotes |
and |
tok272 |
63-70 |
VB |
denotes |
prevent |
event38 |
63-70 |
I_ACTION |
denotes |
prevent |
tok273 |
71-78 |
NN |
denotes |
illness |
tok274 |
79-90 |
NN |
denotes |
progression |
tok275 |
90-91 |
, |
denotes |
, |
tok276 |
92-95 |
CC |
denotes |
and |
tok277 |
96-98 |
PRP |
denotes |
we |
tok278 |
99-104 |
VBD |
denotes |
found |
tok279 |
105-114 |
NN |
denotes |
lopinavir |
tok280 |
114-115 |
NN |
denotes |
/ |
tok281 |
115-124 |
NN |
denotes |
ritonavir |
tok282 |
125-133 |
VBN |
denotes |
combined |
event4 |
125-133 |
OCCURRENCE |
denotes |
combined |
tok283 |
134-138 |
IN |
denotes |
with |
tok284 |
139-145 |
NN |
denotes |
abidol |
tok285 |
146-152 |
VBD |
denotes |
showed |
event33 |
146-152 |
OCCURRENCE |
denotes |
showed |
tok286 |
153-169 |
NNS |
denotes |
antiviraleffects |
tok287 |
170-172 |
IN |
denotes |
in |
lookup40 |
170-172 |
country_code |
denotes |
in |
tok288 |
173-179 |
NNP |
denotes |
COVID- |
tok289 |
179-181 |
CD |
denotes |
19 |
tok290 |
181-182 |
. |
denotes |
. |